Cargando…
Correction: CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
Autores principales: | Xie, Tao, Fu, Du-jiang, Li, Zhi-min, Lv, Dao-jun, Song, Xian-Lu, Yu, Yu-zhong, Wang, Chong, Li, Kang-jin, Zhai, Baoqian, Wu, Jiacheng, Feng, Ning-Han, Zhao, Shan-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591373/ https://www.ncbi.nlm.nih.gov/pubmed/37872619 http://dx.doi.org/10.1186/s12943-023-01881-0 |
Ejemplares similares
-
CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling
por: Xie, Tao, et al.
Publicado: (2022) -
SMARCC1 Suppresses Tumor Progression by Inhibiting the PI3K/AKT Signaling Pathway in Prostate Cancer
por: Xiao, Zhao-Ming, et al.
Publicado: (2021) -
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021) -
Fibroblast Growth Factor 11 Enables Tumor Cell Immune Escape by Promoting T Cell Exhaustion and Predicts Poor Prognosis in Patients with Lung Adenocarcinoma
por: Zhai, Baoqian, et al.
Publicado: (2023) -
COLLABORATION AGREEMENT No. K 1322
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2006)